1.Multiple Genetic Marker Analysis wih Using Quantitative RT-PCR in Gastric Cancer.
Moon Won YOO ; Hyuk Joon LEE ; Soo Min CHOI ; Jieun YU ; Keun HUR ; Young Kook KIM ; Han Kwang YANG
Journal of the Korean Gastric Cancer Association 2007;7(2):59-66
PURPOSE: This study was aimed at evaluating the diagnostic validity of peritoneal dissemination of gastric cancer cells by performing multiple genetic marker analysis via quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in gastric cancer cell lines and gastric cancer tissues. MATERIALS AND METHODS: Quantitative RT-PCR was performed on 12 human gastric cancer cell lines and 10 gastric cancer tissues with four mRNAs of carcinoembryonic antigen (CEA), Cytokeratin 20 (CK20), dopa decarboxylase (DDC), and L-3-phosphoserine phosphatase (L3PP). RESULTS: Out of the 12 human gastric cancer cell lines we tested, CEA was overexpressed in four cell lines (33%), CK20 in one (8%), DDC in six (50%) and L3PP was expessed in all the lines (100%). Out of the 10 gastric cancer tissues we tested, CEA was overexpressed in nine tissues, CK20 in eight, DDC in nine and L3PP was overexpressed in all the tissues. L3PP was overexpressed in all the gastric cancer cell lines and tissues, but the levels of overexpression were lower than those of CEA and DDC. CONCLUSION: Multiple genetic marker analysis can compensate for the weak points of single marker analysis when testing gastric cancer, and three mRNAs of CEA, DDC and L3PP can be used as candidate genes.
Carcinoembryonic Antigen
;
Cell Line
;
Dopa Decarboxylase
;
Genetic Markers*
;
Humans
;
Keratin-20
;
RNA, Messenger
;
Stomach Neoplasms*
2.Heterogeneous expression of DOPA decarboxylase to improve the production of dopamine in Escherichia coli.
Fuqiang SONG ; Wujiu CHEN ; Fengli WU ; Xiaoshuang WANG ; Fuping LU ; Qinhong WANG
Chinese Journal of Biotechnology 2021;37(12):4266-4276
Dopamine is the precursor of a variety of natural antioxidant compounds. In the body, dopamine acts as a neurotransmitter that regulates a variety of physiological functions of the central nervous system. Thus, dopamine is used for the clinical treatment of various types of shock. Dopamine could be produced by engineered microbes, but with low efficiency. In this study, DOPA decarboxylase gene from Sus scrofa (Ssddc) was cloned into plasmids with different copy numbers, and transformed into a previously developed L-DOPA producing strain Escherichia coli T004. The resulted strain was capable of producing dopamine from glucose directly. To further improve the production of dopamine, a sequence-based homology alignment mining (SHAM) strategy was applied to screen more efficient DOPA decarboxylases, and five DOPA decarboxylase genes were selected from 100 candidates. In shake-flask fermentation, the DOPA decarboxylase gene from Homo sapiens (Hsddc) showed the highest dopamine production (3.33 g/L), while the DOPA decarboxylase gene from Drosophila Melanogaster (Dmddc) showed the least residual L-DOPA concentration (0.02 g/L). In 5 L fed-batch fermentations, production of dopamine by the two engineered strains reached 13.3 g/L and 16.2 g/L, respectively. The residual concentrations of L-DOPA were 0.45 g/L and 0.23 g/L, respectively. Finally, the Ssddc and Dmddc genes were integrated into the genome of E. coli T004 to obtain genetically stable dopamine-producing strains. In 5 L fed-batch fermentation, 17.7 g/L of dopamine was produced, which records the highest titer reported to date.
Animals
;
Dopa Decarboxylase/genetics*
;
Dopamine/biosynthesis*
;
Drosophila melanogaster/genetics*
;
Escherichia coli/metabolism*
;
Humans
;
Metabolic Engineering